Expanding Research and Development Support Products and Diagnostic Reagent Sales
First written in FY2016. 1 of 2 entries say "Dropped", first in FY2018. Latest entry: FY2018.
0 other companies' latest entry also says "Dropped".
- FY2018DroppedAnnual report
「○ Medical equipment business: Sales of medical equipment ○ SPD business: Supplies and information management and procurement management services ○ Nursing-care products business: Sales and rental of beds and supplies for home care ○ Import and sales business: Import and sale of medical devices」
The company does not disclose the life sciences business or sales of R&D support products and diagnostic reagents as separate business themes, disclosing only the 4-business structure after the integration. - FY2016First statedAnnual report
「In the basic research field, customers increased their adoption of equipment supporting corporate research and development, and some customers increased orders for products needed for research. In the diagnostic reagents field, although large testing equipment had been replaced in the previous fiscal year, sales of diagnostic reagents used to test for infectious diseases and blood coagulation progressed, securing revenue at a level comparable to the previous fiscal year.」
The life sciences business operates through supplies and products for research and development and the sale of diagnostic reagents, but it is reporting an operating loss.